The present disclosure provides compounds of Formula I which can be tuned to provide agonistic or antagonistic toll-like receptor (TLR) bining properties. Further provided herein are pharmaceutical compositions comprising compounds described herein, as well as methods of using such compositions to treat a disease or condition in a subject.